Introduction {#s0001}
============

mRNA transport is an important mechanism for focusing protein expression to specific regions of cells, to individual cells in a group of interconnected cells, or even to regions of an organism in cases where its nuclei share a common cytoplasm. mRNA localization plays important functions wherever spatial restriction of protein expression is needed and the importance of mRNA localization for normal development and physiology is underlined by the fact that this mechanism is found form bacteria to humans.[@cit0001] *Drosophila* oocytes and embryos are well-established systems to study mRNA localization. Oocyte determination depends on mRNA localization and the spatial localization of *bicoid (bcd), oskar (osk)* and *gurken (grk)* transcripts determines the embryonic anterior-posterior axis as well as the dorsal-ventral axis already during oogenesis.[@cit0002] During the syncytial blastoderm stage of embryonic development pair-rule transcripts, such as *fushi tarazu (ftz), even-skipped (eve)* and *hairy (h)* become localized via microtubule (MT) minus-end directed transport to the apical cytoplasm, above the layer of nuclei. Their local translation in the apical cytoplasm close to the nuclei allows the local synthesis of the transcription factors encoded by them. This is an efficient way to produce the proteins where they are needed and to restrict diffusion to the surrounding nuclei. Other transcripts that are targeted apically to the nuclei are the mRNA encoding the signaling molecule Wingless (Wg), which is subsequently translated and secreted apically, and the *inscuteable* (*insc*) mRNA that becomes apically localized in neuroblasts.[@cit0003] Altogether, 71% of the genes expressed during *Drosophila* embryonic development show discernable subcellular mRNA localization patterns.[@cit0006]

In *Drosophila*, mRNA localization involves a machinery composed of Bicaudal-D (BicD) and Egalitarian (Egl), which interact with dynein/dynactin microtubule motors on the one hand and with the mRNA cargo on the other (reviewed in[@cit0001]). In this way the mRNA cargo is targeted to distinct cellular compartments. While we have learned much about the genes and proteins involved in mRNA transport and localization, until recently we knew only a small number of mRNAs that use the BicD/Egl localization machinery for their transport. Here we describe many novel mRNAs localized by BicD/Egl. The results for the top candidates were validated in independent experiments and in several ways. Aside from quantifying their enrichment during immunopurification with qPCR, we also included genetic analyses combined with in situ mRNA localization experiments to confirm that these mRNAs indeed require *BicD* to reach their target regions. This approach also revealed novel cellular compartments that are targeted by the BicD/Egl transport machinery in embryos and ovaries. Finally we used the resource we established to develop a search algorithm to identify putative A\'-form-like localizing elements in 3′UTRs. Testing two of the newly identified putative localization sequences revealed that the program successfully identified novel localizing signals in the 3′UTR of novel Egl targets.

Results {#s0002}
=======

RIPseq uncovers novel putative Egl targets {#s0002-0001}
------------------------------------------

Anti-GFP antibodies were used to immunoprecipitate Egl-associated mRNAs from cytoplasmic extracts prepared from 0--8 hours old *Drosophila* embryos expressing a functional Egl::GFP fusion protein.[@cit0007] As control for unspecific binding we used extracts from wild type embryos lacking the GFP epitope. Immunoprecipitation (IP) conditions were optimized by analyzing the enrichment of known BicD/Egl mRNA targets in the experimental IP compared to the control IP ([Fig. 1A, B](#f0001){ref-type="fig"}). This procedure efficiently co-immunoprecipitated Egl::GFP, BicD and endogenous Egl ([Fig. 1A](#f0001){ref-type="fig"} and data not shown). Because BicD forms dimers,[@cit0008] this likely indicates that a multimeric Egl::GFP/BicD/BicD/Egl complex was pulled down. The apically localizing mRNAs *h, ftz* and *wg*[@cit0004] were strongly enriched in the Egl::GFP precipitates compared to the controls ([Fig. 1B](#f0001){ref-type="fig"}). The abundance of 2 mRNAs that get localized through BicD/Egl during oogenesis (*osk, bcd*) was also elevated in the embryonic Egl::GFP IP. As negative controls we tested the known non-localized transcripts from *Krüppel* (*Kr*) and *string* (*stg*), which are not recruited to the BicD/Egl localization machinery in embryos[@cit0010] and we included the house keeping genes *Tub67C, RpL32, Act5C* and *Act42C* ([Fig. 1B](#f0001){ref-type="fig"}). While we observed residual amplification of all transcripts in the control IPs (*wt*; probably due to minor amounts of unspecific binding to the beads), only localized mRNAs showed a clear enrichment in the Egl::GFP IP ([Fig. 1B](#f0001){ref-type="fig"}). Enrichment was observed when using the same amount of pulled down total RNA ([Fig. 1B](#f0001){ref-type="fig"}) and the same amount of initial embryonic material, respectively (Fig. S1). Figure 1.RipSeq protocol retains BicD/Egl complex stability and enriches for known target mRNAs. (A-B) Extracts from *Egl::GFP* expressing embryos and *wt* control extracts were subjected to IP with anti-GFP antibodies. Western blotting tested for the presence of the BicD and Egl::GFP (A). Semiquantitative RT-PCR tested for the enrichment of known BicD/Egl mRNA targets and for the lack of enrichment of non-localizing mRNAs and house keeping mRNAs (B). (C) Rip-Seq enrichment of mRNAs from the test set. (D-E) Most top candidate BicD/Egl targets identified by Rip-Seq (D) could be validated by RT-qPCR analysis in an independent IP experiment (E). Error bars represent +/− SD of 2 independent IPs. Note that fold enrichment values of the 2 different experiments cannot be compared directly because they are calculated using different formulas (see methods). Nevertheless, enrichments in the Egl::GFP IPs relative to mock IPs is reproducible.

Immunoprecipitations were performed with 2 independent biological samples of Egl::GFP and controls. Biological replicates were pooled for Illumina sequencing and enrichment factors and P-values were determined and compiled (Table S1). Many of the known BicD/Egl mRNA cargoes such us *osk, bcd, insc, nos, orb* and *Chc* mRNAs were found to be highly enriched in the Egl::GFP IPs and they ranked in the top 140 enriched mRNAs, while our non-localizing mRNAs were not in this group ([Fig. 1C](#f0001){ref-type="fig"}; Table S1). Therefore, the preparative purification scheme effectively enriched for Egl mRNA targets. Using the known target *osk* mRNA as a cut off, a list of the top 50 mRNAs with the highest enrichment scores was produced. [Table 1](#t0001){ref-type="table"} lists the embryonic expression data for these genes and [Table 2](#t0002){ref-type="table"} their oogenesis expression data. These predicted targets were selected for further analysis. Interestingly, many top candidate mRNAs show higher enrichment values than the already described Egl targets ([Fig. 1D](#f0001){ref-type="fig"}). Because the known BicD/Egl targets had been identified by genetic and not by biochemical experiments and because many of them perform their function primarily in the ovarian germ line, it is not surprising that we identified mRNAs that are more enriched than the already known ones. To our knowledge this was the first biochemical approach taken to identify targets of this machinery and it revealed numerous novel mRNAs that seem to attach significantly and specifically to Egl:GFP. Table 1.Localization patterns of Egl::GFP target mRNA candidates in embryonic stages 1--5.Gene-IDpValFold changeEmbryo expression (St. 1 to 5, our data)Embryo expression (St. 1 to 5, published-data)Maternal expressionCG343571.08E-06217.53NENA egl2.10E-0542.33Ubiquitous, maternalUbiquitous, degraded by st.4 (Mach and Lehmann, 1997) (BDPG)✓snmRNA:3311.60E-0424.87NANA CG61511.60E-0426.38Not expressedUbiquitous- weak (BDPG)✓hts3.03E-0421.1NAAnterior gradient (Ding et al., 1993) (Yue and Spradling, 1992)✓CG42663 =     CG124884.34E-0429.6Ubiquitous-weakNot expressed (BDPG) mus210 = Xpc4.63E-0419NAAnterior gradient. apical enrichment (BDPG)✓Fatp = CG74009.80E-0420.15Ubiquitous-weakWeak anterior gradient (BDPG)✓CG88411.37E-0314.4Gap expression pattern- apical and pole cell enrichmentMaternal (BDPG)✓mu21.59E-0313.9NAAnterior gradient (Kasravi et al., 1999)✓CG53772.00E-0314.8Ubiquitous-weakUbiquitous, early degraded (BDPG)✓dap2.28E-0312.4NAUbiquitous. Pole plasm- pole cell enrichment (BDPG)✓CG331292.50E-0311.9Pole cell enrichment-weakUbiquitous (BDPG), pole cell enrichment (Fly-Fish)✓RpS292.60E-0311.7Ubiquitous-strongUbiquitous (BDPG)✓CG109622.62E-0354.1Ubiquitous-weakUbiquitous, apical exclusion St. 4--5 (Fly-Fish)✓grk3.26E-0312NAUbiquitous-weak, degraded completely st.5 (Fly-Fish)✓Tsp39D3.49E-0331.3Ubiquitous-weakNA RpL383.73E-0313.4UbiquitousNA Acf13.94E-0310.6Apical enrichment in cycles 13--14Ubiquitous, degradation of maternal transcripts (Fly-Fish, BDPG)✓CG42600 = clos3.96E-0311.1Basal localizationNA Sry-α5.87E-039.4Perinuclear- apical enrichment-strongPerinuclear St. 1--3, apical enrichment, St. 4--5 (Fly-Fish). Ubiquitous (BDPG)✓CG43340 =     CG304926.37E-039.1Basal localizationUbiquitous, degradation maternal transcripts (Fly-Fish)✓Dok6.85E-038.9Apical and pole cell enrichment (weak)Ubiquitos, perinuclear. St. 4--5 apical and pole cell enrichment (Biswas et al., 2006, Fly-Fish, BDPG)✓CG49498.39E-0310.3NAUbiquitous, St. 1--3, St. 4--5 apical enrichment (Fly-Fish ). Ubiquitous faint, St. 1--3, St. 4--5 apical and pole cell enrichment (BDPG)✓CG401601.02E-0212.6Weak ubiquitousWeak ubiquitous (Fly-Fish)✓lok1.03E-028Gap-expression-anterior gradient.St 4--5 segmented pattern. Apical, pole plasm and pole cell enrichmentGap-expression-anterior gradient. St 4--5 segmented pattern, apical and pole plasm, pole cell enrichment (Fly-Fish, Oishi et al., 1998, BDPG)✓nos1.04E-027.8Pole plasm and pole cell enrichment, maternalPole plasm and pole cell enrichment. (Wang and Lehmann, 1991)✓a1.05E-027.9Apical-anterior gradientFirst ubiquitous and then gap-expression anterior gradient (Liu and Lengyel, 2000)✓T481.22E-027.8Apical- ventral enrichmentVentral enrichment (Kölsch et al.2007) pgc1.41E-027.4Pole plasm and pole cell enrichment, maternalPole plasm and pole cell enrichment, perinuclear (Martinho et al., 2004, BDPG, Fly-Fish)✓Rab91.44E-029.4Basal localizationMaternal (BDPG)✓CG129451.60E-027.7Basal localization-faint stainingMaternal, rapidly degraded (BDPG)✓insc1.78E-026.8NANE (BDPG) pbl1.81E-026.7NAPole plasm and pole cells (Prokopenko et al., 2000, Fly-Fish)✓didum1.95E-026.6UbiquitousUbiquitous (Bonafe and Sellers, 1998)✓RpS152.03E-026.3Ubiquitous-strongUbiquitous (BDPG)✓tefu2.11E-027.7Ubiquitous -weakBasal, apical and pole cell exclusion (Fly-Fish)✓snoRNA:U3:9B2.13E-0219.4NANA fs(1)N2.40E-026.1UbiquitousMaternal deposited, degraded by St 4 (BDPG)✓CG176982.51E-0210.1UbiquitousSt. 1--3 no expression, St. 4--5, faint ubiquitous, yolk nuclei (BDPG) nmdyn-D62.74E-0213.4Ubiquitous-weakNA CG332982.88E-026.2Ubiquitous-weakSt. 1--3 ubiquitous, hindgut anlage in statu nascendi (BDPG). St.1--3 ubiquitous weak, St. 4--5 subset anterior blastoderm nuclei (Fly-Flish)✓CG64592.91E-025.9Ubiquitous-weakSt .1--3, ubiquitous-weak, degraded completely at St. 5 (BDPG, Fly-Fish)✓CG56043.00E-025.7Ubiquitous-weakNo expression (BDPG) ptr3.30E-025.5Ubiquitous-weakSt .1--3, ubiquitous-weak, degraded completely at St. 5 (BDPG, Fly-Fish)✓CG58773.89E-026.3Ubiquitous-weakNA Mitf3.96E-025.7Basal enrichment-posterior enrichmentProcephalic ectoderm anlage in statu nascendi (BDPG)✓CG35853.97E-025.1Basal enrichment-weakNA✓Uba14.17E-024.9Maternal, ubiquitous. Apical enrichment-weakUbiquitous St.1--5 (BDPG). Not expressed (Fly-Fish)✓osk4.29E-024.9Pole plasm and pole cellsPole plasm and pole cells (Ephrussi et al., 1991)✓[^2] Table 2.Localization patterns of Egl::GFP target mRNA candidates in ovaries.Gene-IDOvary expressionDOT (Dresden Ovary table)Consistent with being transported by BicD/Egl in ovaries and/or embryosCG34357NENDNEeglOocyte enrichment (Mach and Lehmann 1997), Apical in follicle cell epitheliaOocyte enrichment. Apical in follicle cell epithelia✓snmRNA:331NANDNACG6151Oocyte enrichmentOocyte enrichment✓htsOocyte enrichment (Yue and Spradling, 1992)ND✓CG42663 = CG12488Oocyte enrichmentND✓mus210 = XpcOocyte enrichmentOocyte enrichment✓Fatp = CG7400Oocyte enrichmentOocyte enrichment✓CG8841Ubiquitous-strong (oocyte and nc expression equal)ND✓mu2Oocyte enrichment (Kasravi et al., 1999)ND✓CG5377Ubiquitous-very weakND dapOocyte enrichment (de Nooij, J.C., et al., 2000)ND✓CG33129Oocyte enrichment- Apical in follicle cell epitheliaOocyte enrichment- Apical in follicle cell epithelia✓RpS29Ubiquitous-strong (stronger in nc than in the oocyte)ND CG10962Ubiquitous-strong (oocyte and nc expression equal)Nurse cell nuclei foci✓grkOocyte enrichment (Neuman-Silberberg and Schupbach, 1993)Oocyte enrichment✓Tsp39DUbiquitous-very weakND RpL38Ubiquitous- strong (stronger in nc than oocyte)ND Acf1Oocyte enrichmentND✓CG42600 = closOocyte enrichmentND✓Sry-αUbiquitous-weakND✓CG43340 = CG30492Oocyte enrichmentND✓DokOocyte enrichmentOocyte enrichment✓CG4949NAOocyte enrichment✓CG40160Ubiquitous (stronger in nc than in the oocyte)Somatic cells follicle cells, no images✓lokOocyte enrichment (Oishi et al., 1998)Oocyte enrichment✓nosOocyte enrichment (Wang et al., 1994)ND✓aOocyte enrichmentND✓T48Oocyte enrichmentND✓pgcOocyte enrichmentOocyte enrichment✓Rab9Oocyte enrichment (St.2 to 6)Oocyte enrichment and/or ubiquitous (pattern not reproducible)✓CG12945Ubiquitous-weak (stronger in nc than in the oocyte)ND inscOocyte enrichmentOocyte enrichment✓pblNAND✓didumOocyte enrichment (MacIver et al., 1998)Oocyte enrichment✓RpS15Ubiquitous-strong (slightly stronger in nc than oocyte)ND tefuUbiquitous-weak (oocyte and nc expression equal)ND✓snoRNA:U3:9BNANDNAfs(1)Noocyte enrichmentOocyte enrichment✓CG17698Ubiquitous-strong (slightly stronger in nc than oocyte)Nuclear foci somatic cells nc and follicle cells nmdyn-D6Ubiquitous-very weakND CG33298Ubiquitous-strong (oocyte and nc expression equal)ND✓CG6459Ubiquitous-strong (stronger in nc than in the oocyte in ealry stages). St. 9 more accumulation in the oocyte.ND✓CG5604Oocyte enrichment (St.4 to 6)ND✓PtrUbiquitous-strong (oocyte and nc expression equal)ND✓CG5877Ubiquitous-strong (stronger in nc than oocyte)ND MitfUbiquitous (oocyte and nc expression equal)ND✓CG3585Oocyte enrichment (St.4 to 6)ND✓Uba1Oocyte enrichment. Apical in follicle cell epitheliaOocyte enrichment✓oskOocyte enrichment (Ephrussi et al., 1991)ND✓[^3]

Validation of top Egl target candidates {#s0002-0002}
---------------------------------------

We validated the 28 top candidates in independent experiments by qPCR ([Fig. 1E](#f0001){ref-type="fig"}), comparing their enrichment again to known BicD/Egl targets as well as to non-localizing transcripts from the same IPs. 27 of these 28 putative novel Egl target candidates turned out to be enriched in anti Egl::GFP IPs compared to the mock IPs. The fold enrichment values from the qPCR analysis cannot be compared directly with the ones from the sequencing experiment because they are normalized and calculated using different parameters (see methods). Nevertheless, both experimental methods revealed a higher enrichment score than the known Egl targets for most of the top hits. The enrichment was also observed when comparing the Egl::GFP IPs to the total input mRNA (not shown). Only the enrichment of *RpS29* could not be confirmed. The fact that this mRNA showed also no specific localization pattern by *in situ* hybridization (see bellow, [Tables 1 and 2](#t0001 t0002){ref-type="table"}) suggests that this is a false positive hit. This indicates that our approach to find novel targets gives consistent results even with different analysis tools and that results are reproducible in independent IPs.

Egl target mRNAs are enriched for specific localization patterns {#s0002-0003}
----------------------------------------------------------------

BicD/Egl is needed to transport mRNAs from the nurse cells into the oocyte and to the apical region in embryos. To validate the data set we therefore analyzed the subcellular localization of the top 50 mRNAs in ovaries and embryos. We searched for known embryonic and ovarian localization patterns in the literature and the following databases: Fly-Fish[@cit0006] (<http://fly-fish.ccbr.utoronto.ca>), BDPG (<http://insitu.fruitfly.org/cgi-bin/ex/insitu.pl>) and DOT[@cit0011] (<http://tomancak-srv1.mpi-cbg.de/DOT/main.html>). The different localization patterns found for Egl candidates are summarized in [Table 1](#t0001){ref-type="table"} and [2](#t0002){ref-type="table"}. *snmRNA:331*/*snRNA:7SK* and snoRNA:U3:9B were not analyzed and the expression of *CG34357* was bellow detection. Because *pbl* expression was only studied in embryos, the localization of 47 top candidates was studied in embryos and 46 top candidates in ovaries.

Because the purification was performed with embryonic extracts as starting material, we expected the identified mRNAs to show specific localization patterns during embryogenesis. 10 mRNAs localized to the embryonic pole plasm and/or pole cells, 10 localized apically of the syncytial blastoderm nuclei and 4 of them showed both localization patterns ([Table 1](#t0001){ref-type="table"}, examples in [Figs. 2, 3](#f0002 f0003){ref-type="fig"}). Interestingly, these locations are cellular compartments where components of the BicD/Egl complex can also be found enriched.[@cit0010] Surprisingly however, Egl protein showed a strong posterior localization ([Fig. 2A](#f0002){ref-type="fig"}), while posterior anti BicD staining was only slightly elevated ([Fig. 2B](#f0002){ref-type="fig"}) and sometimes even not recognizably.[@cit0012] Examples of mRNAs showing preferential localization to the pole plasm and pole cells are shown in [Fig. 2C](#f0002){ref-type="fig"}. Figure 2.Egl targets are enriched for mRNAs localizing to pole plasm and pole cells. 21% (10/47) of the BicD/Egl targets localize to the pole plasm or pole cells compared to 8.4% of a random set.[@cit0006] (A) Egl protein is enriched in the pole plasm (upper panels, embryo in syncytial division before polar bud formation) and in pole cells (lower panels, embryo in late stage 4). (B) BicD protein signal is detected slightly enriched in pole plasm and pole cells. Stages are as in A). (C) *In situ* hybridization to whole-mount wild-type embryos (*wt, OreR)* using antisense RNA probes for the candidate mRNAs *CG8841, lok, Dok* and *CG33129*. Hoechst (blue) visualizes the DNA. Scale bars are 30 μm.

Among the apically localizing mRNAs some showed a continuous apical distribution along the a-p body axis. These are *Acf1, lok (chk2/mnk*), *Dok, Sry-a* and *Uba1* ([Fig. 3A](#f0003){ref-type="fig"}). Others, however, were enriched apically but displayed a non-uniform pattern of expression along one of the body axes ([Fig. 3B--D](#f0003){ref-type="fig"}). *arc (a)* mRNA was enriched apically in the anterior region of the embryo ([Fig. 3B](#f0003){ref-type="fig"}) and consistent with this localization, Arc protein was also localized apically in several epithelia.[@cit0013] Arc has been reported to be a component of adherens junctions and to be required for eye and wing development.[@cit0013] *T48* mRNA signal was enriched apically, but only in the ventral region. This apical localization remarkably correlates with its protein localization and its function in ventral furrow formation ([Fig. 3C](#f0003){ref-type="fig"};[@cit0014]). *CG8841* is apically enriched at the anterior and posterior poles, in a dorsal-ventral stripe in the middle of the embryo, and it accumulates in the pole cells ([Fig. 3D](#f0003){ref-type="fig"}, [Fig. 2C](#f0002){ref-type="fig"}). Interestingly, the *CG33129* mRNA shows apical localization in invaginating furrows during gastrulation and also in tracheal precursor cells later in embryogenesis ([Fig. 3E--F](#f0003){ref-type="fig"}). The apical enrichment of these mRNAs in cells that are undergoing morphogenetic movements suggests that localization of this mRNA and the protein it encodes might play a role in the apical movement of these cells. Figure 3.Egl targets show specific and novel apical localization patterns. Apically localizing mRNAs are 6-fold enriched compared to a published random set (10/47; 21% vs 3.4%[@cit0006]). *In situ* hybridizations to wild-type (*OreR)* embryos oriented anterior to the left and dorsal up. Hoechst (blue) visualizes the DNA. (A) Novel transcripts showing continuous apical localization in blastoderm embryos (red signal). Apical localization varies and changes for different mRNAs and nuclear cycles, respectively. *RpL38* mRNA *in situ* was used as a control that shows the distribution of a non-localizing mRNA. (B-D) Novel candidates expressed apically but not continuously from anterior to posterior. (B) *arc (a)* is enriched apically of the nuclear layer in the anterior region of the embryo (green signal). (C) *T48* is enriched apically only in the ventral region (green signal). (D) *CG8841* shows apical enrichments at the anterior and posterior poles (including pole cell expression) and in the middle of the embryo (green signal). *CG33129* (red signal) shows apical localization in the invaginating furrows during gastrulation (E) and in tracheal precursor cells (stained for the Tango (Tg) marker in green) later in embryogenesis (F). Scale bars represent 25 µm except in (F) were they represent 30 µm. Histograms depicted on the right side of the pictures show the fluorescence intensity along the apical-basal axis of the marked region around a blastoderm nucleus (dotted square). This region is also shown magnified on the right side.

*in situ* hybridization experiments revealed that 28 of the 46 (61%) mRNAs expressed in ovaries showed clear enrichment in the oocyte relative to the nurse cells at some point during oogenesis ([Table 2](#t0002){ref-type="table"}, [Figs. 4, 5](#f0004 f0005){ref-type="fig"} and Fig. S2). Eight additional mRNAs (17%) displayed strong oocyte staining even though the oocyte signal was not higher than the nurse cell signal ([Table 2](#t0002){ref-type="table"}, [Fig. 4](#f0004){ref-type="fig"} and Fig. S2). Because transcription in the female germ line is almost exclusively happening in nurse cell nuclei, this distribution pattern most likely requires active transport as well. Consistently, we also found that 79% of the Egl::GFP target candidates were expressed maternally in embryos ([Table 1](#t0001){ref-type="table"}). Interestingly, many oocyte enriched mRNAs displayed specific subcellular localization patterns. Most of them localized posteriorly up to stage 6 and then relocalized to the anterior cortex ([Table 2](#t0002){ref-type="table"}, [Figs. 4, 5](#f0004 f0005){ref-type="fig"} and Fig. S2). Additionally, 3 of the oocyte-enriched candidates were also expressed in the somatic follicle cells of the ovary where they localized apically ([Table 2](#t0002){ref-type="table"}, [Fig. 5A](#f0005){ref-type="fig"}). Work with different mRNAs had shown previously that this localization pattern is also dependent on dynein.[@cit0015] In summary, the present knowledge about the function of BicD/Egl in mRNA localization can explain for about 80% of the top candidates ([Table 2](#t0002){ref-type="table"}) why they have been isolated. Figure 4.Egl targets are enriched for mRNAs that localize to the oocyte in a BicD dependent manner. 61% of the BicD/Egl targets tested showed accumulation in the oocyte compared to the expected 17% observed in a random set of mRNAs. *In situ* hybridization to wild-type (*OreR)* controls and to egg chambers 4 d after turning off *BicD* expression (*BicD*^*mom*^). Antisense RNA probes for the candidate mRNAs were labeled with green or red fluorescent signals. Almost no *BicD* mRNA signal is observed when *BicD* expression is off (green signal, upper-most panels). During early wild-type oogenesis, *clos, fwe, lok, CG43340, nos, T48*, and *a* accumulated in the oocyte where they became enriched at the posterior till stage 6. Subsequently the signal appeared at the anterior cortex by stage 7, showing this pattern until mid to late oogenesis (left panels). These mRNAs failed to efficiently accumulate in *BicD*^*mom*^ oocytes when *BicD* was off and the late localization in the oocyte was also severely impaired in *BicD*^*mom*^ oocytes (right panels). *CG6459* showed expression in the oocyte cytoplasm at all stages. However, in this case the oocyte signal was not enriched compared to its accumulation in nurse cells. A weak *BicD* dependent concentration of the mRNA at the dorsal side of the oocyte nucleus was observed by stage 8 (arrowhead, and magnified region in inset picture). By stage 9 a more clear presence of a dotted *CG6459* signal was observed in the oocyte, but levels did not seem to exceed nurse cell levels. In *BicD*^*mom*^ ovarioles big blobs of *CG6459* mRNA signal were seen in the nurse cell cytoplasm, suggesting a problem in transport of this mRNA. Hoechst (blue) visualizes the DNA. Scale bars are 20 µm. Figure 5.*BicD* is needed for apical mRNA localization in follicle cells. 6.5% of the mRNA tested show apical localization in follicle cells. This mRNAs class is enriched 8-fold among the Egl::GFP targets compared to a random set (6.5% vs 0.8%[@cit0011]) (A) *In situ* hybridization to wild-type (*OreR, wt)* controls and to egg chambers 4 d after turning off *BicD* expression (*BicD*^*mom*^). Oocyte enrichment (arrows) as well as apical follicle cell localization of *CG33129, egl* and *Uba1* was impaired when *BicD* was off. High magnification of the stage 10 follicle cell epithelium is shown in the right panels. Note that apical is toward the oocyte (up in the magnified pictures). Scale bars are 20 µm. *Uba1* apical enrichment is weaker and less cortical, but still requires *BicD*. Histograms depicted on the right side of the pictures show the fluorescence intensity along the apical-basal axis of the marked cortical region around the nuclear layer (dotted square). This region is also shown magnified on the right side of the micrographs. (B) *BicD* mRNA expression (red) is drastically reduced in stage 9--10 *BicD*^*mom*^ egg chambers in the germline and also in the somatic follicle cells (high power pictures on the right). Note that *BicD* mRNA is also apically localized as expected since it is also a target of Egl. (C) BicD protein (red) is also apically enriched in wild-type follicle cells, but is almost undetectable in *BicD*^*mom*^ egg chambers, oocytes and follicle cells. Hoechst (blue) visualizes the DNA. Scale bars are 20 µm.

To systematically analyze whether the BicD/Egl targets are enriched for specific gene ontology (GO) groups we also compiled an extended top target list. Sorted according to cellular components, the members of this list were significantly (p \< 0.05) enriched for mRNAs that encode cytoplasmic proteins, components of the pole plasm and of ribonucleoprotein granules (Fig. S3A). Among the biological processes, developmental processes such as germ cell development, oocyte and embryonic axis specification, cell fate determination and cell maturation were predominant (Fig. S3B). Interestingly, these processes are well known for their dependence on mRNA localization. The enrichment of molecular functions is, however, less clear (Fig. S3C). While nucleotide and RNA binding proteins might be expected, we presently do not know why calmodulin binding proteins made it to the top of the list.

Localization of Egl target candidates requires *BicD* {#s0002-0004}
-----------------------------------------------------

To test whether the localization of the candidate mRNAs indeed depends on the BicD/Egl localization machinery we used the *BicD*^*mom*^ flies described previously to turn off *BicD* expression in the germ line once the oocyte is made.[@cit0016] Around 4 d after shutting down *BicD* expression, ovaries contained egg chambers with strongly reduced or undetectable levels of *BicD* mRNA and BicD protein ([Figs. 4, 5B--C](#f0004){ref-type="fig"} and[@cit0017]). Indeed, at the time *BicD* mRNA became undetectable, oocyte enrichment of the candidate mRNAs was severely impaired ([Fig. 4](#f0004){ref-type="fig"}), indicating that the top candidate Egl::GFP targets indeed depend on *BicD* for their localization. mRNAs from *egl, CG33129* and *Uba1* showed oocyte enrichment as well as apical localization in the somatic follicle cells. Interestingly, their localization was affected in both cell types in *BicD*^mom^ ovaries ([Fig. 5A](#f0005){ref-type="fig"}). Because *BicD* mRNA ([Figs. 4, 5B](#f0004 f0005){ref-type="fig"}) and BicD protein ([Fig. 5C](#f0005){ref-type="fig"}) levels were not only reduced in the germ line, but also in the follicle cells, it appears that the BicD/Egl machinery also localizes mRNAs apically in the somatic tissue of the female gonad.

To study the involvement of *BicD* in localizing mRNAs that are enriched in the embryonic pole plasm, we studied transcript localization in embryos from mothers carrying a dominant *BicD*^*IIIE48*^ allele. Embryos laid by such mothers lack anterior structures and many of them show a strong double abdomen phenotype called bicaudal.[@cit0018] A large proportion of the BicD protein gets mislocalized to the anterior of these embryos, producing ectopic anterior localization of the posterior mRNA determinants *osk* and *nos*, 2 BicD/Egl targets.[@cit0012] *lok* mRNA is enriched in the pole plasm and pole cells of wild-type embryos[@cit0020] ([Fig. 2C](#f0002){ref-type="fig"}, Fig. S4). Embryos from *BicD*^*IIIE48/r5*^ mothers showed additional enrichment of *lok* mRNA at the anterior of the young embryo (Fig. S4) providing good evidence that the *lok* mRNA is a target of BicD/Egl in embryos as well.

Putative localization elements in Egl target mRNAs {#s0002-0005}
--------------------------------------------------

mRNA localization motives facilitating the binding to the BicD/Egl localization machinery could so far not be predicted based on their primary sequence. NMR studies of the *K10 TLS* localization signal showed that it forms a stem-loop with 2 double-stranded RNA helices adopting an unusual A′-form conformation.[@cit0021] These helices were associated with runs of 3 or more purines on one side of the stem. Consistently, stem-loops within the mapped localization elements of well known BicD/Egl targets, such as *grk, ftz, h, bcd, wg, osk* and the *I-factor* RNAs, contain 2 or more stretches of at least 3 contiguous purines on the same side of the stem.[@cit0021] Based on this we set up a bioinformatics approach to predict functionally important helices of this kind in our candidate mRNA data set. We expect such signals to be conserved between different *Drosophila* species. Accordingly, orthologous sequences from 10 *Drosophila* species were aligned based on their secondary structure prediction. Conserved stem-loops were then sorted for the presence of 2 or more stretches of at least 3 contiguous purines on the same side of the stem. Using this approach we optimized the program by searching for the known BicD/Egl dependent localization hairpins (Fig. S5). For each hairpin we then plotted the conservation across *Drosophila* species against the percentage of bases that make pair bonds for each hairpin (this serves as a simplified measurement of the hairpin stability). We found that in the case of *h, orb, grk, K10, osk* and *bcd* the best predicted localizing A\'-form hairpin (best conserved and with highest frequency of base matches) coincided with the known hairpins responsible for apical or oocyte localization of the transcripts[@cit0021]; Fig. S5). In the case of *wg* and *ftz* the program still predicted the known localization sequences and they were among the best scoring ones, but not at the top. It is possible that in these cases the presence of redundant localization signals or the high conservation intrinsic to open reading frames (ORFs) was distorting the values (see Discussion). We also consider it possible that the 2 best predicted hairpins in *ftz* and *wg* are the main localization elements in several other *Drosophila* species, but have become partially redundant with new ones in *melanogaster*.

We next analyzed the Egl:GFP targets that showed a clear oocyte, pole plasm or apical enrichment in ovaries or embryos for the presence of conserved predicted A\'-form helices (Fig. S6 and Fig. S7). Two mRNAs, *pgc* and *sry-*α, showed the presence of only one putative A\'-form type helix, and this was identified in their ORF (Fig. S7). *lok, Dok, fs(N)1* and *T48* have one most likely localization hairpin that shows the best folding energy and is highly conserved (Fig. S6A) The analysis of *CG33129, egl, a, mus210/Xpc, insc, dap* and *fatp/CG7400* revealed that although the best-scoring hairpin might likely be the localizing signal, some other hairpins would probably need to be tested as well (Fig. S6 and Fig. S7). Similarly *CG43340, didum, CG12488, Uba1, Acf1, CG8841, fwe* and *hts* have at least 2 putative A\'-form helices with high scores (Fig. S6 and Fig. S7). We selected *Dok* and *lok* to test the localization activity of the predicted hairpins ([Fig. 6](#f0006){ref-type="fig"}) by injecting fluorescently labeled RNAs into the basal cytoplasm of syncytial embryos and following their apical transport. For *lok*, the most highly conserved A\'-form hairpin resides in the ORF, but there is also one in the 3′UTR that, although less conserved, has the highest frequency of base matches (Fig. S6A). Only *lok* sequences containing the 3′UTR supported apical localization, while fragments containing the ORF regions did not localize ([Fig. 6A, C C\'](#f0006){ref-type="fig"},). Furthermore, deletion of the predicted conserved A\'-form in the 3′ UTR greatly impaired apical localization of the 3′UTR region ([Fig. 6B, D, D\'](#f0006){ref-type="fig"}). Similarly, the best predicted A\'-form hairpin of *Dok* was also identified in the ORF (Fig. S6A), but the ORF RNA alone did not support apical transport ([Fig. 6E, G, G\'](#f0006){ref-type="fig"}). In contrast, the 3′UTR localized strongly to the apical side ([Fig. 6E, G, G\'](#f0006){ref-type="fig"}) and the deletion of its predicted 3′UTR A\'-form stem loop abolished most of the transport ([Fig. 6E--G, G\'](#f0006){ref-type="fig"}). Egl protein is recruited to its target RNAs injected into the basal region of the embryo and it gets co-transported apically with the RNA.[@cit0010] Injecting *lok* and *Dok* 3′ UTRs, but not the corresponding constructs lacking the localizing hairpins, also led to an apical enrichment of Egl above the site of injection ([Fig. 7A--D](#f0007){ref-type="fig"}). The bioinformatics predictions can therefore reveal functional localization elements in the 3′ UTR that serve to localize these mRNAs apically by the BicD/Egl transport machinery. Figure 6.3′ UTR hairpins of *Dok* and *lok* are responsible for apical localization. (A, E) Schematic representations of the test *lok* (A) and *Dok* (E) mRNAs injected. (B, F) Secondary structure of the localizing hairpins in *lok* (B) and *Dok* (F) predicted using the *RNAfold* web server. (C, D, G) Representative images of embryos injected with the respective *lok* (C-D) and *Dok* (G) constructs indicated above each picture. Fluorescently labeled transcripts (green signal) were injected into blastoderm embryos basally and fixed 12 min thereafter. Images are oriented with apical at the top. Hoechst (blue) visualizes the DNA. The categorization of the RNA enrichment to the apical cytoplasm for the corresponding injections shown in (C, D, G) is shown under each embryo image (C\', D\', G\'). The percentage of embryos showing strong (++), weak (+), very weak (+/−) or no apical (−) localization is shown for each construct. (N) Number of embryos scored for each mRNA injection. Scale bars are 10 µm. Figure 7.Recruitment of Egl to apically localizing *Dok and lok 3′ UTRs*. (A-D) Immunostaining revealed the distribution of Egl (red) following basal injection of *lok* (green) (A, B) and *Dok* RNA fragments (C, D) into wild-type embryos. Egl is co-recruited to apically localized *Dok* and *lok* 3′ UTR sequences (A, C), but not if the localizing hairpin sequence was deleted from the construct (B, D). Scale bars are 10 µm.

Discussion {#s0002-0006}
----------

We have identified BicD/Egl mRNA targets in 0--8 hour old *Drosophila* embryos and found that 80% of the top candidates showed localization patterns that are compatible with their being actively transported during oogenesis and/or during the first 4 hours of embryogenesis by the BicD/Egl dependent localization machinery. At present we do not know for most of the remaining transcripts whether they are transported by Egl during different developmental stages, whether a competing process prevents their accumulation at the expected target site or whether the Egl-mediated transport also leads to yet uncharacterized distribution patterns. For *CG33129*, however, we observed that the transcripts are also localized apically in later stages in the tracheal precursors and *insc* is known to be localized in older embryos apically in the neuroblasts.[@cit0003] Compared to a random group of mRNAs,[@cit0006] the BicD/Egl top targets described here show a 6-fold enrichment for apically localizing embryonic mRNAs (10/47; 21% vs 3.4%). Similarly 21% (10/47) of the BicD/Egl targets are also enriched for mRNAs that localize to the pole plasm or pole cells compared to the reported 8.4% of a random set.[@cit0006] Compared to a random set of mRNAs[@cit0011] we also observed a 3--4-fold increase in oocyte accumulation among the BicD/Egl targets (61% vs 17%) and an 8-fold increase in apical follicle cell localization (6.5% vs 0.8%) although our sample size for this phenotype is very small (n = 3). The same localization patterns were also enriched in a statistical analysis that took into account a much larger group of *Egl* targets (see Fig. S3D, E). In contrast, basally localized transcripts were clearly underrepresented in our data set (Fig. S3D). The enrichment for specific mRNA localization patterns in ovaries and embryos indicates that the BicD/Egl machinery specifically acts for nurse cell to oocyte transport, for apical transport of mRNAs during oogenesis and embryogenesis, and for enrichment in the pole plasm and pole cells. All these processes indeed involve a polarized MT network and the BicD/Egl/Dynein machinery. These results further imply that different subcellular localization patterns identified for other mRNAs are generated by different mechanisms or at least require an additional element. The multitude of different mRNA localization patterns described for instance by the high throughput screens[@cit0006] are therefore likely to involve additional mechanisms such as mRNA diffusion coupled with entrapment and degradation, and active transport utilizing different transport systems.

The data set of apically localized mRNAs bound to Egl can be grouped into 3 functional groups: 1) Genes with nuclear functions, involved in DNA metabolism, DNA repair, chromosome structure and DNA damage response. 2) Genes coding for proteins that associate directly or indirectly with the plasma membrane. 3) Genes coding for secreted proteins. The first group includes the genes like *lok* that encodes the *Drosophila* Chk2 kinase involved in monitoring DNA damage, *Mutagen-sensitive 210* (*Mus-210*, also *Xpc)*, which encodes a protein with DNA binding domains and a predicted DNA repair function, and *Acf1* (ATP-dependent chromatin assembly factor 1), which is involved in the assembly and maintenance of heterochromatin.[@cit0020] Also belonging to this group of nuclear proteins are the transcription factors encoded by the segmentation genes *h* and *ftz*. At the time the proteins encoded by these mRNAs become active, their target nuclei are also positioned apically. It thus appears that the localization of their mRNAs facilitates an efficient reaching of their target site by the encoded protein. Furthermore, as for the apically localized mRNAs with striped localization patterns like *ftz* and *h* (but also *wg, CG8841, a, T48)*, the apical localization of these transcripts might serve to avoid lateral diffusion of their products to the neighboring nuclei and compartments. For example, Acf1 is a subunit of the nucleosome-remodeling complex involved in chromatin assembly and chromatin-mediated gene repression, and in *Acf1* mutants heterochromatin assembly is disturbed.[@cit0023] Interestingly, when pericentric heterochromatin forms during the blastoderm stages, it is localized to the apical side of the nuclei, adjacent to where we found *Acf1* mRNA localized. Because *Acf1* mRNA localization depends on *BicD* activity,[@cit0025] it appears that *BicD* and *egl* might also play a role in heterochromatin assembly by localizing *Acf1* mRNAs in embryos.

The second group contains mRNAs encoding proteins that associate with the plasma membrane. The PDZ domain protein Arc is a component of the adherens junctions. Protein and mRNA reside apically in several epithelia, and in embryos they are found in regions that undergo morphogenetic movements, such us invagination, elongation or convergent extension.[@cit0013] Serendipity α (Sry-α) is associated with the plasma membrane and with actin invaginations during cellularization at the blastoderm stage.[@cit0026] Dok is a signaling protein required upstream of JNK signaling during dorsal closure. It is found at the cell cortex associating with the plasma membrane where it is ideally positioned to respond to Src signaling.[@cit0027] T48 is a transmembrane protein that is needed together with G protein signaling to recruit adherens junctions and cytoskeletal regulators to sites of apical constriction during ventral furrow formation.[@cit0014] Remarkably, *CG8841*, the novel pole plasm component that displays additional apical mRNA localization, encodes a predicted transmembrane domain protein, too.

The localization of most Egl target mRNAs in ovaries depends on *BicD*. This testifies to the quality of the data presented in the candidate list and it suggests that aside from the top candidates, the list may contain numerous additional targets with lower scores. Indeed, known BicD/Egl targets, like *Chc, orb, K10, h* and *ftz* appear further down in the list with lower enrichment scores (Table S1). While validating the BicD/Egl targets we noticed that *BicD* is also required for apical localization of many mRNAs in "normal" somatic cells (aside from the syncytial embryo). However, loss-of-function mutations in *egl* and *BicD* were initially isolated as female sterile mutants because of their essential function in the female germ line.[@cit0028] The fact that we now also found Egl target mRNAs that are apically localized in developing tracheal cells and in salivary glands (data not shown), together with the known role for *BicD* in localizing *insc* mRNA in neuroblasts, suggest that this machinery is also working in somatic embryonic and larval cells and tissues where a polarized cytoskeleton is present. This indicates that mRNA localization by BicD/Egl is at work in many different cell types, but that it is more important in large cells, such as the female germ line, the syncytial embryo and the nervous system. This is consistent with the *BicD*^*null*^ phenotype, which reveals important zygotic functions for this gene. Most *BicD*^*null*^ animals die during larval stages but a very small fraction makes it to adulthood. Such adults are uncoordinated and lethargic and die within 2 d.[@cit0029]

Taking advantage of the new pool of verified Egl target mRNAs and of the published NMR structure of the K10 localization signal, we also set up a bioinformatics approach to identify A\'-form hairpin structures in Egl-bound mRNAs. Interestingly, although most of the conserved A\'--form hairpins were predicted to be located in the ORF of the mRNAs (Fig. S6D), we could not validate their functionality in the 2 cases we tested. Instead A\'--form hairpins identified in the 3′UTR turned out to serve as functional localization elements. This suggests that giving priority to the hairpins found in the 3′ UTR should improve the chance of finding the correct localization sequences. One reason for this could be that hairpins of ORFs that are in a state of repressed translation - bound to translational repressors or to a repressed translation machinery - may be masked such that the transport machinery cannot bind to them. In contrast, the 3′ UTR may be free of stalled ribosomes and accessible for recruitment by the transport complex. Another possibility is that additional sequences in the 3′UTR serve as binding site for additional factors that may facilitate Egl binding. Similarly, embedding the localization signal in the context of the 3′UTR, which is more AT rich than the ORF, may facilitate the folding of the Egl recognition structure. This view is also supported for example by the finding that the efficient localization of *h* and *ftz* is context dependent with sequences surrounding the minimal localization signal working non autonomously, but enhancing the activity of the localization element.[@cit0030]

Material and methods {#s0003}
====================

Purification of Egl bound mRNAs {#s0003-0001}
-------------------------------

RNA immunoprecipitations were performed essentially as described with some modifications.[@cit0032] Briefly, protein G Sepharose beads (Gamma bind Plus agarose, Roche) were washed 3 times with blocking buffer (20 mM HEPES pH 7.9, 150 mM KCl, 20% glycerol containing 0.5% Tween-20, 1mg/ml BSA, 2 mg/ml heparin and EDTA free protease inhibitors, Roche). Beads were then blocked for 3 h at RT with the same buffer. 1 ml of monoclonal anti-GFP antibody supernatant was added per 40 μl of blocked beads and incubated for 2 h at RT with gentle rotation. Coated antibody beads were then washed with non-hypotonic buffer (20 mM HEPES pH 7.9, 2mM MgCl~2~, 150 mM KCL, 1mM DTT, 20% glycerol containing 0.5% Tween and EDTA free protease inhibitors, Roche). For extract preparation, 1 gr of 0--8 h old embryos were dechorionated and homogenized in 2 ml hypotonic buffer (20 mM HEPES pH 7.9, 2 mM MgCl~2~, 10 mM KCL, 1 mM DTT containing 0.5% Tween-20, EDTA free protease inhibitors, Roche, and RNase inhibitor, Biolabs, 100 units/ml). All further steps were performed at 4°C. The homogenized extract was cleared at 10,000 × g for 20 min. For each IP 323 μl of salt adjusting buffer (20mM HEPES pH 7.9, 57% glycerol, 0.4M KCl, 2mM MgCl~2~, 1mM DTT) and 2 μl of RNase free DNase I (20 U/ml, Roche) were added to 600 μl of cleared supernatant. This salt adjusted extract was added to 40 μl of coupled antibody beads and incubated overnight at 4°C with rotation. The immunoprecipitate was washed 8 times with high salt wash buffer (20 mM HEPES pH 7.9, 2 mM MgCl~2~, 200 mM KCL, 20% Glycerol, 1mM DTT containing 0.5% Tween, EDTA free protease inhibitors and RNase inhibitor (Biolabs, 100 units/ml)), rotating it for 10 min, followed by centrifugation at 2,000 rpm for 2 min. Beads were treated with 30 μg of Proteinase K (Roche) in proteinase K buffer (150 mM NaCl, 12.5 mM EDTA, 10 % SDS, 0.1M Tris-HCL pH 7.5) in a total volume of 100 μl for 30 min at 55°C. RNA was extracted using the Trizol reagent (Invitrogen) following the manufacture\'s instructions. The integrity and quality of the co-immunoprecipitated RNA was assessed using the Agilent RNA 6000 Nano Kit on an Agilent 2100 bioanalyzer (Agilent Technologies) following the manufacturer\'s instructions.

Preparation of the library for sequencing {#s0003-0002}
-----------------------------------------

The material of 2 independent IPs was pooled and used for library preparation (15 µl of RNA with 47,7 ng/µl for the control IP and with 73,7 ng/µl for the Egl::GFP IP) following the manufacture\'s instructions (TruSeq RNA Sample Prep Kit V2, Illumina, La Jolla, USA).

RT-PCR and RT-qPCR analysis {#s0003-0003}
---------------------------

The RNA from each IP was resuspended in 25 μl of DEPC treated water and its quality was analyzed with the Eukaryote Total RNA Nano chip in an Agilent bioanalyzer. RT-PCR assays were performed to optimize the RNA IP protocol. For this, sequences were amplified using the Access RT-PCR system (Promega) and primers that spanned introns. Optimal cycle numbers were determined for each gene.15 ng of IPed RNAs were used as template for each RT-PCR reactions. Using the same amount for the Egl::GFP IPs and the control IPs allows us to normalize the total number of reads from the subsequent sequencing reaction even though it will produce an underestimated enrichment value. The enrichment for localizing mRNAs but not for housekeeping genes was also observed when using the same amount of embryonic material for normalization. No amplification was observed in reactions without RT, indicating that we do not observe amplification from DNA.

For RT-qPCR assays, cDNAs from the different samples were prepared with the SuperScript II Reverse Transcriptase and oligo dT primers (Invitrogen) following the manual\'s instructions and using 133 ng of IPed mRNAs. Primers used for the RT-qPCR analysis were designed in a way that one of a pair spanned an exon-junction sequence and that the amplicon length ranged from 100 to 150 bp. Sequences were amplified using the QuantiTect SYBR Green PCR Kit (Qiagen) and a Rotor Gene instrument (Qiagen). Calculation of mRNA levels was done using the 2 \[-ΔΔC(~T~)\] method.[@cit0033] Fold enrichment (mRNA levels present in the IP over mRNAs levels in the mock IP) was plotted. C(~T~) values used were the means of duplicate technical and biological repeats.

Bioinformatics analysis of Illumina data {#s0003-0004}
----------------------------------------

The two single-end RNAseq libraries produced 49 M and 52 M reads with a read length of 100bp on an Illumina HiSeq2000 Instrument (Illumina, La Jolla, USA). The quality of the reads was assessed using FastQC (version 0.10.1, [www.bioinformatics.babraham.ac.uk/projects/fastqc](http://www.bioinformatics.babraham.ac.uk/projects/fastqc)) and reads mapping to rRNA genes (∼80%) were removed. The remaining reads (9,5 M and 10,8 M reads) were mapped to the fly genome (version 5.45 of the Flybase) using the spliced alignment approach implemented in TopHat2 version 2.0.5.[@cit0035] For each annotated gene (annotation version 5.45 of Flybase) we counted the number of reads mapping to it using the program HTSeq-count ([www.w-huber.embl.de/users/anders/HTSeq](http://www.w-huber.embl.de/users/anders/HTSeq), version 0.5.3). To test for significant differences of gene expression levels between the *Egl::GFP* and the *y w* control the R÷package DESeq was used.[@cit0036] More precisely, raw read counts were normalized to the total number of reads, and the variation of read counts per gene was assumed to follow the variation of counts across genes. The reported p-value is corrected for multiple testing following Benjamini and Hochberg.[@cit0037] Fold enrichment represent the ratio between the normalized reads from the Egl IP over the control IP. GO term enrichment analysis was done with the website <http://geneontology.org>.

Fluorescent in situ hybridization (FISH) to whole mount embryos and ovaries and immunostainings {#s0003-0005}
-----------------------------------------------------------------------------------------------

Plasmids (BDGP resources;[@cit0038]) containing the cDNA of the candidate genes were linearized with the corresponding restriction enzymes (New England Biolabs) and used as templates to generate digoxigenin- or Fluorescein (FITC)-labeled RNA antisense probes. *In situ* hybridization experiments on ovaries and embryos were performed essentially as described[@cit0039] but 5% milk powder (Rapilat) in PBT (PBS, 0.1% Tween) was used as blocking reagent. The digoxigenin labeled probes were detected with sheep-anti-digoxigenin antibodies and Cy3-conjugated donkey anti-sheep IgG F(ab\')2 fragments (Jackson Immunoresearch). Fluorescein-labeled probes were detected with mouse anti-fluorescein antibodies (Roche) and Cy3-conjugated goat anti-mouse antibodies (Jackson Immunoresearch). For double RNA in situs, Cy3-conjugated anti-mouse antibodies and Cy5-conjugated anti-sheep antibodies were used (Jackson Immunoresearch). Immunostainings were done using the following primary antibodies: mouse anti-BicD (1B11, 1: 10 dilution;[@cit0041]) anti-Egl (1:5,000 dilution;[@cit0042]). Where required, nuclei were stained for 20 min with 2.5 µg/ml of Hoechst 33258 during the final wash step. Images were analyzed with a Leica TCS-SP8 or Leica TCS-SP5 confocal microscopes. Different pictures were taken for each egg chamber in an ovariole focusing on the oocyte center. The picture showing the entire ovariole was then assembled in Adobe Photoshop. All patterns described were observed reproducibly and were observed in most of the embryos and ovaries analyzed. Histograms depicting the fluorescence along the apical-basal axis were done using Fiji software.

Fluorescent RNA synthesis and injections {#s0003-0006}
----------------------------------------

RNAs for injections were synthesized in the presence of Alexa-488-UTP (Molecular probes) as described.[@cit0010] *Dok* and *lok* RNAs were synthesized using LD32155 and LD27875 plasmids, respectively (BDGP resources). The *Dok* (1--2271) DNA template was generated by linearizing the corresponding plasmid with BamHI. The *lok* plasmid was linearized with SphI or BamHI and used as template to generate *lok* (1--948) and *lok* (1--1495) transcripts. Deletion of the corresponding localizing hairpins in *Dok* and *lok* 3′ UTR was done on LD32155 and LD27875 by site directed mutagenesis. Wild-type and deleted forms of the 3′ UTR regions were amplified by PCR and used as templates for transcription. Fluorescently labeled RNAs were used at 0.5--1 μg μl^−1^. Fixing was done 12 min after injection of the last embryo and immunofluorescent staining of injected embryos was done as described.[@cit0010] Images were analyzed with a Leica TCS-SP8 confocal microscope. Strong localization means that most of the signal was in the apical cytoplasm. Weak localization means most signal remained basally, but there were some apical caps of signal; "in very weak localization" apical cap signals were barely above background fluorescence of the basal cytoplasm while no fluorescent puncta were observed in the apical cytoplasm in "no apical localization."

Stem loop predictions {#s0003-0007}
---------------------

The sequences of the candidate genes were retrieved from FlyBase (release 5.1). The longest isoform of every gene was chosen. Local secondary structures were explored by means of RNALfold, from the Vienna package[@cit0043] (version 2.1.8), with the following options: 25°C temperature and no "lonely pairs." A conservation score for the *Drosophila melanogaster* genome was available on the UCSC genome browser.[@cit0044] It was computed by means of PhastCons[@cit0045] on the multiple alignment of the dm3 genome with:- *D. simulans* (droSim1)- *D. sechellia* (droSec1)*- D. yakuba* (droYak2)*- D. erecta* (droEre2)- *D. ananassae* (droAna3)- *D. pseudoobscura* (dp4) - *D. persimilis* (droPer1)- *D. willistoni* (droWil1)- *D. virilis* (droVir3) - *D. mojavensis* (droMoj3) - *D. grimshawi* (droGri2)- *A. gambiae* (anoGam1) - *A. mellifera* (apiMel3) - *T. castaneum* (triCas2)

Predicted hairpins were further analyzed for the presence of at least 2 A/G stretches, each at least 3 nucleotides in length. Overlapping hairpins were removed, retaining the ones with the lowest energy. Hairpins with a conservation score higher than 0.5 and longer than 40 nt were reported.
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[^1]: Supplemental data for this article can be accessed on the [publisher\'s website](http://dx.doi.org/10.1080/15476286.2016.1251542).

[^2]: Top Egl::GFP mRNAs are sorted by pVal. NA: not analyzed; NE: no expression; ✓: these genes show maternal expression. Known Egl targets are grk, nos, insc, osk.

[^3]: NA: not analyzed; ND: no data available; NE: no expression; nc: nurse cells; ✓: these genes show localization in ovaries or embryos ([Table 1](#t0001){ref-type="table"}) compatible with their being transported by the BicD/Egl machinery. Known Egl targets are grk, nos, insc, osk..
